<amendment session="108" chamber="h" number="215" updated="2013-07-17T08:16:05-04:00">
  <amends type="h" number="2660" sequence="2"/>
  <status datetime="2003-07-10T15:12:00-04:00">pass</status>
  <sponsor id="400023"/>
  <offered datetime="2003-07-10"/>
  <description>Amendment earmarks $12 million for research on the comparative effectiveness, cost effectiveness, and safety of drugs, biological products, and devices.</description>
  <purpose>An amendment numbered 5 printed in the Congressional Record to provide that $12 million shall be available for the conduct of research on the comparative effectiveness, cost-effectiveness, and safety of drugs, biological products and devices.</purpose>
  <actions>
    <action datetime="2003-07-10T15:05:00-04:00">
      <text>Amendment (A002) offered by Mr. Bereuter.</text>
      <reference ref="CR H6560-6561" label="consideration"/>
      <reference ref="CR H6560" label="text"/>
    </action>
    <vote datetime="2003-07-10T15:12:00-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Bereuter amendment (A002) Agreed to by voice vote.</text>
    </vote>
  </actions>
</amendment>
